Dizziness, a common complaint in clinical practice, often poses a diagnostic challenge due to its multifaceted nature. Vertigo, a subtype of dizziness, is characterized by a sensation of self-motion or environmental movement, and is frequently associated with balance disorders. This article aims to provide healthcare professionals with a comprehensive understanding of vertigo and its clinical approach.
Vertigo is often a symptom of diseases affecting the vestibular system, including labyrinthitis, vestibular neuritis, Meniere's disease, and benign paroxysmal positional vertigo (BPPV). It can also result from central nervous system disorders, such as stroke or multiple sclerosis. Accurate diagnosis is crucial to provide appropriate treatment and prevent potential complications.
Initial evaluation should include a detailed history, focusing on the onset, duration, and triggers of vertigo. Physical examination should assess nystagmus, gait, and balance. Neurological assessment can help identify central causes. Further investigations may include audiometry, vestibular function tests, and neuroimaging, depending on the suspected etiology.
Management strategies depend on the underlying cause. For BPPV, canalith repositioning maneuvers are the first-line treatment. Vestibular suppressants may be used for acute symptomatic relief in various conditions, but long-term use is discouraged due to potential side effects and impairment of central compensation. Vestibular rehabilitation therapy can be beneficial for chronic vertigo. In refractory cases, surgical interventions may be considered.
Vertigo is a complex clinical entity that requires a systematic approach for accurate diagnosis and management. A thorough understanding of its pathophysiology, clinical features, and treatment options is essential for healthcare professionals to provide optimal patient care. Continued research and advancements in diagnostic modalities promise to further enhance our ability to manage this challenging condition.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation